GOSS (Gossamer Bio) Moat Score: 2/10 (As of Jun. 25, 2026)


GOSS Gossamer Bio Inc GOSS
16 GF Score
Price $0.17
! 5 Warning Signs
View Full Analysis

What is Gossamer Bio Moat Score?

Gossamer Bio GOSS -2.65% 16 Moat Score is 2 as of Jun. 25, 2026. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 1,405 Biotechnology companies, Gossamer Bio ranks better than 58.15% on this metric.

Gossamer Bio has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Gossamer Bio has No Moat: Gossamer Bio Inc lacks significant market leadership or durable competitive advantages. The company operates in a highly competitive biotech sector with limited intellectual property and no significant customer switching costs or regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Gossamer Bio might have No Moat - Very weak/transient advantages.

Gossamer Bio  (NAS:GOSS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Gossamer Bio Moat Score Related Terms

GOSS vs TIL, ATYR, HYPD: Moat Score Comparison

For the Biotechnology subindustry, Gossamer Bio's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gossamer Bio Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gossamer Bio's Moat Score distribution charts can be found below:

* The bar in red indicates where Gossamer Bio's Moat Score falls into.


GOSS
16GF Score
Gossamer Bio Inc GOSS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Gossamer Bio (GOSS) has a Moat Score of 2 as of Jun. 25, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Gossamer Bio ranks #588 out of 1405 companies in the Biotechnology industry, placing it in the top 41.9%.
Is Gossamer Bio's Moat Score too high?
Gossamer Bio's current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Gossamer Bio's value of 2 is 0% at this industry median. Based on the distribution chart, Gossamer Bio ranks #588 out of 1405 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's Moat Score compare to TIL and ATYR?
According to the Biotechnology industry distribution chart, Gossamer Bio ranks #588 out of 1405 companies for Moat Score. This puts Gossamer Bio in the upper half of its industry. The industry median Moat Score is 2.00. Gossamer Bio's value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,405 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gossamer Bio's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gossamer Bio's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current Moat Score is 2 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gossamer Bio Business Description

Other Exchanges 4GB:Germany
Address 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score

Get the complete analysis for GOSS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price